In this report, we have demonstrated that in addition to regulating several tumor suppressor miRNAs and downstream oncogenic targets, DCLK1 inhibition results in upregulation of miRNAs that negatively regulate several key pluripotency and pro-angiogenic factors. This evidence concerns the gene DCLK1 and neoplasm.